We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open65.47
High65.47
Low65.47
Prev. Close66.81
Avg. Traded Price65.47
Volume87,626

MARKET DEPTH

info2
Total bid0.00
Total ask53,796.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
65.471429510
65.51800
65.61500
65.6516
66.0523977

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

65.479 hours ago
65.479 hours ago
arrow

LOWER/UPPER CIRCUITS

65.47
68.14
arrow
Aarey Drugs Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 20.16%, in the last year to ₹483.76 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteInterest Coverage Ratio,is 3, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
noteDebt to Equity Ratio,of 0.25 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : -6.46%
Aarey Drugs & Pharmaceuticals Ltd.is engaged in the manufacturing of drugs and intermediates such as metronidazole metronidazole benzoate methyl and nitro imidazole. The Therapeutic targets of the company's products are Allergy Dermatology & Infectious Diseases
personal

Grow your wealth with more research recommendations

+91